DK1771572T3 - P75NTR-screeningsassay for identifikation af modulatorer af apoptose - Google Patents
P75NTR-screeningsassay for identifikation af modulatorer af apoptoseInfo
- Publication number
- DK1771572T3 DK1771572T3 DK05766804T DK05766804T DK1771572T3 DK 1771572 T3 DK1771572 T3 DK 1771572T3 DK 05766804 T DK05766804 T DK 05766804T DK 05766804 T DK05766804 T DK 05766804T DK 1771572 T3 DK1771572 T3 DK 1771572T3
- Authority
- DK
- Denmark
- Prior art keywords
- apoptosis
- p75ntr
- modulators
- identification
- screening assay
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04103368 | 2004-07-14 | ||
| US58855104P | 2004-07-16 | 2004-07-16 | |
| PCT/EP2005/053304 WO2006005740A2 (fr) | 2004-07-14 | 2005-07-11 | Essai de depistage de p75ntr |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1771572T3 true DK1771572T3 (da) | 2009-02-16 |
Family
ID=39243741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05766804T DK1771572T3 (da) | 2004-07-14 | 2005-07-11 | P75NTR-screeningsassay for identifikation af modulatorer af apoptose |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8637464B2 (fr) |
| EP (1) | EP1771572B1 (fr) |
| AT (1) | ATE411393T1 (fr) |
| AU (1) | AU2005261721B2 (fr) |
| CA (1) | CA2571130C (fr) |
| DE (1) | DE602005010436D1 (fr) |
| DK (1) | DK1771572T3 (fr) |
| ES (1) | ES2315889T3 (fr) |
| WO (1) | WO2006005740A2 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011163241A2 (fr) * | 2010-06-21 | 2011-12-29 | Georgetown University | Composés neuroprotecteurs |
| WO2014049556A2 (fr) * | 2012-09-28 | 2014-04-03 | The University Of Queensland | Signalisation des récepteurs de neurotrophine-tyrosine kinase |
| EP2950095B1 (fr) * | 2014-05-28 | 2018-08-29 | Technische Universität Dresden | Analyse cellulaire et procédés de criblage de modulateurs de signalisation de p75NTR |
| IT202000007720A1 (it) * | 2020-04-10 | 2021-10-10 | Alessandra Marconi | Peptidi e loro usi |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU689248B2 (en) * | 1994-04-11 | 1998-03-26 | Nexins Research B.V. | A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample |
| ATE408688T1 (de) * | 1998-10-06 | 2008-10-15 | Univ Queensland | Polypeptide zur modulierung des überlebens von zellen |
| FR2801320B1 (fr) * | 1999-11-19 | 2002-02-15 | Inst Nat Sante Rech Med | Procede d'evaluation de la genotoxicite d'un compose |
| US6881719B2 (en) | 2000-01-18 | 2005-04-19 | Mcgill University | β-turn peptidomimetic cyclic compounds |
-
2005
- 2005-07-11 DE DE602005010436T patent/DE602005010436D1/de active Active
- 2005-07-11 AU AU2005261721A patent/AU2005261721B2/en not_active Ceased
- 2005-07-11 DK DK05766804T patent/DK1771572T3/da active
- 2005-07-11 AT AT05766804T patent/ATE411393T1/de not_active IP Right Cessation
- 2005-07-11 CA CA2571130A patent/CA2571130C/fr not_active Expired - Fee Related
- 2005-07-11 WO PCT/EP2005/053304 patent/WO2006005740A2/fr active Application Filing
- 2005-07-11 US US11/632,395 patent/US8637464B2/en not_active Expired - Fee Related
- 2005-07-11 ES ES05766804T patent/ES2315889T3/es active Active
- 2005-07-11 EP EP05766804A patent/EP1771572B1/fr not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| ES2315889T3 (es) | 2009-04-01 |
| CA2571130C (fr) | 2014-08-19 |
| EP1771572B1 (fr) | 2008-10-15 |
| CA2571130A1 (fr) | 2006-01-19 |
| US8637464B2 (en) | 2014-01-28 |
| WO2006005740A3 (fr) | 2006-06-29 |
| WO2006005740A2 (fr) | 2006-01-19 |
| EP1771572A2 (fr) | 2007-04-11 |
| US20080064036A1 (en) | 2008-03-13 |
| AU2005261721B2 (en) | 2011-02-24 |
| ATE411393T1 (de) | 2008-10-15 |
| DE602005010436D1 (de) | 2008-11-27 |
| AU2005261721A1 (en) | 2006-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002087306A3 (fr) | Bioanalyse a haut rendement basee sur des cellules, permettant de surveiller l'activite du canal sodique et de decouvrir des composes modulant la sensation de gout sale | |
| DE69430573D1 (de) | Test und reagentien zur identifizierung von antiproliferierenden stoffen | |
| Yang et al. | Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China | |
| ATE430936T1 (de) | Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome | |
| ATE386815T1 (de) | Methoden und syteme zur überwachung intrazellulärer bindereaktionen | |
| ATE269974T1 (de) | Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung | |
| BRPI0515079A (pt) | marcadores imobilizados e métodos de detecção de prions conformacionalmente alterados | |
| ATE382148T1 (de) | Antikörper für apoptosemarker und anwendungsverfahren | |
| RU2015132436A (ru) | Способы обнаружения активности протеазы в биологических системах и композиции для их осуществления | |
| ATE377654T1 (de) | Ubiquitin-ligase-assay | |
| DK1771572T3 (da) | P75NTR-screeningsassay for identifikation af modulatorer af apoptose | |
| ATE443775T1 (de) | Hif-prolylhydroxylase-aktivitätstest | |
| JP2013534415A (ja) | Ｎ末端ルール・プロテアーゼ同定方法及びその使用法 | |
| ATE382060T1 (de) | Moleküle und verfahren zur inhibierung der freisetzung von kim-1 | |
| WO2005010215A3 (fr) | Procedes d'identification de composes modulateurs de la tolerance et utilisations de ceux-ci | |
| Li et al. | Development of human in vitro brain-blood barrier model from induced pluripotent stem cell-derived endothelial cells to predict the in vivo permeability of drugs | |
| MXPA04001287A (es) | Ensayo de receptor unido a proteina g. | |
| ATE484749T1 (de) | Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung | |
| ATE354635T1 (de) | Substrat und verfahren zum messen elektrophysiologischer eigenschaften von zellmembranen | |
| MXPA03011898A (es) | Ensayo de seleccion in vitro para ?- secretasa. | |
| ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
| DE60113811D1 (de) | NACHWEIS DER BINDUNG VON Ladungsträgern mittels PH- ODER POTENTiaL-SENSITIVEr SONDEN | |
| ATE514082T1 (de) | Biologischer bodendetektor | |
| CY1105513T1 (el) | Μεθοδοι εξετασης διαλογης ενωσεων που διαμορφωνουν την αποπτωση, ενωσεις αναγνωριζομενες μεσω των εν λογω μεθοδων και η χρηση των εν λογω ενωσεων ως θεραπευτικων μεσων | |
| Duncan et al. | α1 connexin (connexin43) gap junctions and activities of cAMP‐dependent protein kinase and protein kinase C in developing mouse heart |